Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2002
10/17/2002WO2002081447A1 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
10/17/2002WO2002081428A1 Benzene compound and salt thereof
10/17/2002WO2002081398A2 Additives for building industry obtained from by-products and process for their production
10/17/2002WO2002080936A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
10/17/2002WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002WO2002080927A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002WO2002080920A1 Arylacetamido-ketobenzoxazole as cysteine protease inhibitors
10/17/2002WO2002080913A1 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
10/17/2002WO2002080846A2 Epothilone derivatives and methods for making and using the same
10/17/2002WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002WO2002057261A3 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
10/17/2002WO2002049626A3 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired pasticity
10/17/2002WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002WO2002042292A3 Indol derivative and their use as inhibitors of p38 kinase
10/17/2002WO2002034726A3 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/17/2002US20020151724 Such as 1-((4-methoxybenzoyl-D-phenylglycinyl))-4-((isopropylamino)methyl)piperidine hydrochloride as anticoaggulants useful in the treatment of cardiovascular disorders such as thrombosis
10/17/2002US20020151720 Naphthol derivatives
10/17/2002US20020151574 Extracellular signal regulated kinase (ERK); anticancer agents and protein kinase inhibitors
10/17/2002US20020151569 Peroxisome Proliferator Activated Receptors (PPARs) antagonists 4-oxo-5-thiazolidine acetamide derivatives
10/17/2002US20020151555 Pyrimidine matrix metalloproteinase inhibitors
10/17/2002US20020151554 Cyclin-dependent kinase inhibitors such as (4-Amino-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-thiazolyl) (2,3-dihydro-1,4-benzodioxin-6-yl)methanone for treatment of breast, lung, colon, and prostate cancer/tumors
10/17/2002US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
10/17/2002DE10118310A1 New 2-azolyl-cycloalkane-1,3-dione derivatives, useful as pesticides, e.g. fungicides, herbicides, insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents
10/17/2002CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002CA2443031A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002CA2442904A1 Benzamidine derivative
10/17/2002CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002CA2441941A1 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
10/16/2002EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002EP1248771A1 Method for preparing hydroxypicolinic acid derivatives
10/16/2002EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002EP0941218B1 Antithrombotic organic nitrates
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002CN1374960A Novel integrain receptor antagonists
10/16/2002CN1374959A Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
10/16/2002CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002CN1374953A Aromatic nitrogenous six-membered ring compounds
10/16/2002CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002CN1374082A Use of glycogen sulphofoenzyme inhibitor
10/16/2002CN1092658C Mesylate trihydrate salt of 5-(2-(4-(1,2-benziisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2-(1H)-indol-2-one
10/16/2002CN1092653C (4-piperidnyl)-1H-2-benzopyran derivatives used as antipsychotic agent
10/16/2002CN1092649C Thiazolidinone compounds or angina pectoris curing or preventing agent with the same as active ingredient
10/16/2002CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/15/2002USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002US6465501 Azolidines as β3 adrenergic receptor agonists
10/15/2002US6465499 Sulphonylbenzazolones
10/15/2002US6465492 Heterocyclic compounds
10/15/2002US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002US6465484 Tyrosine kinase inhibitors; cancer, atherosclerosis, diabetic retinopathy, autoimmune diseases, inflammatory diseases
10/15/2002US6465467 Diseases related to the 5-ht2c receptor, especially eating, memory, mood, urinary and anxiety disorders, schizophrenia, pain, sexual dysfunctions
10/15/2002US6465456 For therapy of bacterial diseases
10/15/2002US6465449 Heteroaromatic bicyclic derivatives useful as anticancer agents
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002WO2002080159A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079195A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/10/2002WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002WO2002079186A2 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078596A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
10/10/2002WO2002062764A9 Fused heterocyclic compounds
10/10/2002WO2002044173A3 Herbicidal heterocycles
10/10/2002WO2002041881A3 Repinotan kit
10/10/2002US20020147334 Vitronectin Receptor Antagonists
10/10/2002US20020147229 Pharmaceuticals
10/10/2002US20020147205 Heterocyclic compounds
10/10/2002US20020147203 Tyrosine kinase inhibitors
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147188 Protease inhibitors
10/10/2002US20020147186 Side effect reduction
10/10/2002DE10117676A1 Pesticidal composition, useful for controlling fleas and ticks on animals, contains permethrin and imidacloprid, in N-methylpyrrolidone
10/10/2002DE10115922A1 Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Cyclic substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442482A1 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442428A1 Novel tyrosine kinase inhibitors
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002CA2441778A1 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246822A1 Benzofuran derivatives
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP0683774B1 Hypolipidaemic compounds
10/09/2002CN1373754A Antibacterial agents